Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1998
02/28/1998CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods
02/27/1998CA2213893A1 Pharmaceutical compounds
02/26/1998WO1998008101A1 Materials and methods for detection and treatment of immune system dysfunctions
02/26/1998WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
02/26/1998WO1998007844A2 SCREENING ASSAY FOR THE IDENTIFICATION OF AGENTS WHICH ALTER EXPRESSION OF PTH-rP
02/26/1998WO1998007740A1 7α-(κ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7α-(κ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS
02/26/1998WO1998007736A1 Don-1 gene and polypeptides and uses therefor
02/26/1998WO1998007727A1 Highly lipophilic camptothecin derivatives
02/26/1998WO1998007726A1 Substituted pyrrolopyrimidines and processes for their preparation
02/26/1998WO1998007725A1 Purine derivatives and their use as anti-coagulants
02/26/1998WO1998007723A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
02/26/1998WO1998007719A1 Arylsulfonylimidazolone derivatives as an antitumor agent
02/26/1998WO1998007718A1 Non-peptide bombesin receptor antagonists
02/26/1998WO1998007715A1 Novel benzofuran-4-carboxamides
02/26/1998WO1998007714A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor
02/26/1998WO1998007713A1 High molecular weight polymer-based prodrugs
02/26/1998WO1998007711A1 Troponyl piperazines as selective dopamine d4 receptor ligands
02/26/1998WO1998007708A1 Isoxazoline derivatives useful as antimicrobials
02/26/1998WO1998007706A1 New polycyclic phthalazin derivatives and their use
02/26/1998WO1998007705A1 Naphtholactams and lactones as bone morphogenetic protein active agents
02/26/1998WO1998007704A1 Tetrahydroquinoline derivatives as eaa antagonists
02/26/1998WO1998007701A1 Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative
02/26/1998WO1998007699A1 Propionic acid derivatives and applications thereof
02/26/1998WO1998007697A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998WO1998007695A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
02/26/1998WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
02/26/1998WO1998007692A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
02/26/1998WO1998007681A1 Pharmaceutical composition containing 4-oxo-butynic acids
02/26/1998WO1998007449A2 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
02/26/1998WO1998007445A1 Preventive/remedy for frequent urination and urinary incontinence
02/26/1998WO1998007439A1 Method of inhibiting the release of bioactive il-1
02/26/1998WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions
02/26/1998WO1998007434A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same
02/26/1998WO1998007433A1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
02/26/1998WO1998007432A1 Beta2 integrin cell adhesion molecule inhibitors
02/26/1998WO1998007431A1 Cholinesterase inhibitors for treatment of parkinson's disease
02/26/1998WO1998007429A2 Antifungal composition with enhanced bioavailability
02/26/1998WO1998007428A1 Orally applicable formulation of quinolone or naphthyridone carboxylic acids
02/26/1998WO1998007427A1 Cocaine receptor binding ligands
02/26/1998WO1998007426A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes
02/26/1998WO1998007424A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
02/26/1998WO1998007423A1 Method for fighting against myases affecting cattle and sheep populations and compositions for implementing same
02/26/1998WO1998007422A1 Therapeutic treatment for sexual dysfunctions
02/26/1998WO1998007421A1 Medicinal composition
02/26/1998WO1998007420A1 Neuropeptide-y ligands
02/26/1998WO1998007419A1 Aerosol for the therapy of asthma
02/26/1998WO1998007418A1 Il-8 receptor antagonists
02/26/1998WO1998007417A1 Pharmaceutical composition comprising coenzyme q¿10?
02/26/1998WO1998007415A2 Methods for prevention of cellular proliferation and restenosis
02/26/1998WO1998007409A1 Liposomes containing a cisplatin compound
02/26/1998WO1998007400A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease
02/26/1998WO1998007321A1 Method for inhibiting the expression of fas
02/26/1998WO1998003171A3 Use of inhibitors of cyp2a6 for regulating nicotine metabolism
02/26/1998WO1998002546A3 Dna immunization against chlamydia infection
02/26/1998WO1998000151A3 In ovo antibiotic and microbial treatment to diminish salmonellae populations in avians
02/26/1998WO1998000115A3 Stable drug form for oral administration and process for the preparation thereof
02/26/1998WO1998000114A3 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998WO1997044063A3 Dha-pharmaceutical agent conjugates
02/26/1998WO1997044007A3 A barrier cream comprising hexamethylenetetramine or derivative thereof
02/26/1998WO1997041837A3 Microparticles
02/26/1998WO1997038966A3 Cytoprotective compounds
02/26/1998WO1997033622A3 Delivery of nucleic acids by porphyrins
02/26/1998WO1997030701A3 Pharmaceutical compositions for the treatment of glaucoma
02/26/1998WO1997022621A3 Antineoplastic peptides
02/26/1998DE19635525A1 New 7-alpha-(xi-aminoalkyl)- oestratriene derivatives
02/26/1998DE19633968A1 Laxative composition giving improved intestinal function
02/26/1998DE19633480A1 Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren Formulations for oral administration of quinolone and naphthyridonecarboxylic
02/26/1998DE19633268A1 Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung Polymeric bile acid Resorptionsinhibitoren with concomitant bile acid Adsorberwirkung
02/26/1998CA2268051A1 Neuropeptide-y ligands
02/26/1998CA2264284A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998CA2264220A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
02/26/1998CA2264178A1 Method for inhibiting the expression of fas
02/26/1998CA2264074A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
02/26/1998CA2264070A1 Method of inhibiting the release of bioactive il-1
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2264000A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor
02/26/1998CA2263854A1 Don-1 gene and polypeptides and uses therefor
02/26/1998CA2263754A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same
02/26/1998CA2263721A1 Propionic acid derivatives and applications thereof
02/26/1998CA2263708A1 7.alpha.-(.xi.-aminoalkyl)estratrienes, process for preparing the same, pharmaceutical preparations containing said 7.alpha.-(.xi.-aminoalkyl)-estratrienes and their use for preparing medicaments
02/26/1998CA2263671A1 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
02/26/1998CA2263659A1 Preventive/remedy for frequent urination and urinary incontinence
02/26/1998CA2263556A1 Therapeutic treatment for sexual dysfunctions
02/26/1998CA2263441A1 Naphtholactams and lactones as bone morphogenetic protein active agents
02/26/1998CA2263149A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes
02/26/1998CA2262876A1 Purine derivatives and their use as anti-coagulants
02/26/1998CA2262788A1 Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative
02/26/1998CA2261908A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
02/26/1998CA2261756A1 New polycyclic phthalazine derivatives and the use thereof
02/26/1998CA2259515A1 Troponyl piperazines as selective dopamine d4 receptor ligands
02/26/1998CA2259310A1 Materials and methods for detection and treatment of immune system dysfunctions
02/26/1998CA2255966A1 Non-peptide bombesin receptor antagonists
02/26/1998CA2255580A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease
02/26/1998CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
02/26/1998CA2213106A1 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
02/25/1998EP0825220A1 Products derived from 2-imino-2,3-dihydro-1H-indoles, processes of preparation, use in cosmetics and cosmetic compositions using them
02/25/1998EP0825197A2 New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
02/25/1998EP0825193A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
02/25/1998EP0825191A2 Chromanyl-ascorbic acid derivatives, their preparation and use
1 ... 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 6696 6697 6698 6699 6700 6701 6702 6703 6704 6705 ... 7860